Coronavirus live news: Indonesian doctors ill despite Sinovac shots; Tokyo to lift emergency before Olympics | World news

[ad_1]






















Updated








Updated








AstraZeneca price pledge omits some poor countries

AstraZeneca can charge a higher price for its Covid-19 vaccine in dozens of poor countries once the pharmaceutical company decides the pandemic has ended, according to a copy of its contract with Oxford University seen by the Guardian.

The British-Swedish drug firm has promised to provide the vaccine at a not-for-profit price to the developing world in perpetuity, but a review of a redacted version of its contract with Oxford University, obtained by the lobby group Universities Allied for Essential Medicines (UAEM), found the promise excludes many low-income and lower-middle income countries.




A health worker shows a vial of AstraZeneca vaccine during a Covid-19 vaccination drive at a shopping mall in Jakarta, Indonesia, 08 June 2021.

A health worker shows a vial of AstraZeneca vaccine during a Covid-19 vaccination drive at a shopping mall in Jakarta, Indonesia, 08 June 2021. Photograph: Bagus Indahono/EPA

Among those left off the list are 34 countries classified by Unicef and the WHO as being in need of vaccine support, including Sri Lanka, Angola, Timor-Leste, Honduras, Zimbabwe and the Philippines, which could all be charged a higher price once AstraZeneca declares the Covid-19 pandemic has ended.

In contrast to its pharmaceutical competitors, AstraZeneca has forgone billions of dollars in revenue by providing its vaccine at cost price, a promise that was key to securing its partnership with Oxford’s Jenner Institute, where the formulation was developed.

Updated








Deaths in Madrid rose 41% year-on-year during pandemic

Updated








Updated








Health officials in Africa have called for an urgent acceleration in the supply of vaccines to the continent to curb a wave of Covid-19 infections and the evolution of new, potentially dangerous variants.

Updated








Updated








Drought may be ‘the next pandemic’, warns UN

Updated








Previous infection with coronavirus does not necessarily protect against Covid in the longer term, especially when caused by new variants of concern, a study on healthcare workers suggests.

Researchers at Oxford University found marked differences in the immune responses of medical staff who contracted Covid, with some appearing far better equipped than others to combat the disease six months later.

Scientists on the study, conducted with the UK Coronavirus Immunology Consortium, said the findings reinforced the importance of everyone getting vaccinated regardless of whether they had been infected with the virus earlier in the pandemic.

Updated








Updated

[ad_2]

Source link